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Tyrosine hydroxylase activity in slices of caudate
nucleus was increased by morphine (100 mg/kg i.p.)
administered to naive mice. During chronic treatment
with morphine tolerance developed to this effect and
36 h after the final chronic morphine injection there
was a decrease in enzyme activity in this area. There
was no change in tyrosine hydroxylase activity in
slices of diencephalon, brainstem or parietal cortex
from either naive or morphine tolerant mice. There-
fore, changes in tyrosine hydroxylase activity,
measured in vitro, could account for the changes in
dopamine synthesis, but not noradrenaline synthesis,
produced by morphine in vivo.
Introduction
In the present study, the effect of morphine on
the hydroxylation of [14C ]-tyrosine, which is a
measure of the activity of the rate-limiting step in
catecholamine biosynthesis (Nagatsu, Levitt &
Udenfriend, 1964), was investigated to determine
whether changes in the activity of this bio-
synthetic step parallel the changes in cerebral
catecholamine synthesis reported to occur after
the administration of morphine in mice (Smith,
Villarreal, Bednarczyk & Sheldon, 1970; Smith,
Sheldon, Bednarczyk & Villarreal, 1972) and rats
(Clouet & Ratner, 1970).
Methods
Albino Swiss-Webster mice (25-30 g) were decapi-
tated, and their brains removed. Tyrosine
hydroxylase activity was measured in whole brain
homogenates and in brain slices. For the homo-
genates, tyrosine hydroxylase activity was
measured using the method of Waymire, Bjur &
Weiner (1971). The principle of this method is the
collection of [14C1 -COg evolved by the coupled
decarboxylation of [1 C]-L-dihydroxyphenylala-
nine formed from [ 1_14C] -L tyrosine. The protein
content of the samples was measured by the
method of Lowry, Rosebrough, Farr & Randall
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(1951). Tyrosine hydroxylase activity of whole
brain homogenates is expressed as nmol
[ 14C] -CO2 evolved per g brain protein and per min
of incubation.
In order to study the tyrosine hydroxylase
activity in brain slices, four slices (about 0.5 mm
thick) were cut from the diencephalon
(10.07 ± 0.28 mg combined wet weight ± s.e.
mean), brainstem (12.64 ± 0.24 mg), caudate
nucleus (13.50 ± 0.22 mg) and parietal cortex
(18.14 ± 0.31 mg). The four slices from each area
were placed in 0.9 ml of Krebs-Ringer phosphate
buffer (pH 7.4) of the following composition
(mM): NaCl, 121; KCI, 4.9; CaCl2.2H20, 1.3;
MgSO4.7H20, 1.2; Na2HPO4, 12.8; NaH2PO4,
3.0; glucose 20. Also dissolved in this solu-
tion were 2-amino-6,7-dimethyl-4-hydroxy-5,6,7,8-
tetrahydropteridine hydrochloride, I mM and
2-mercaptoethanol, 25 mM. Tyrosine hydroxylase
activity in slices was measured by a modification
of the method of Weiner, Cloutier, Bjur & Pfeffer
(1972). At the end of a 15 min pre-incubation
period, 0.1 ml of [l-'4CJ-L-tyrosine (1.0 gCi/
incubate) was added to give a concentration of
104 M. The ['4C -CO2 evolved during the next
20 min was collected in 0.2 N NCS organic tissue
solubilizer and its radioactivity was counted in a
liquid scintillation spectrometer. Tyrosine
hydrox lase activity of brain slices is expressed as
pmol [ Cl-CO2 evolved per g brain and per min
of incubation.
Results
Hydroxylation of tyrosine was measured in homo-
genates of whole brain where any localized inhibi-
tion of the enzyme had been removed by
disruption. No significant change (t test; P > 0.05)
in the hydroxylation of tyrosine was found 70 min
after the acute injection of morphine (3, 10, 30,
100 or 300 mg/kg i.p.). Similarly, no change was
seen when mice were given the same test doses of
morphine 6 h after chronic morphine treatment
(100 mg/kg i.p. at 6 h intervals for nine injec-
tions). When given either 0.9% w/v NaCl solution
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Fig. 1 Effect of withdrawal from morphine on
tyrosine hydroxylase activity in mouse brain slices
from the caudate nucleus (.), diencephalon (A),
brainstem (o), and parietal cortex (A). Ordinates: rate
of hydroxylation of [1-'4CJ-L-tyrosine in pmol
["4C1-CO2 g brain-' minute-'. Abscissae: time in
hours from ninth morphine injection. Each point
represents the mean of six determinations. Vertical
bars represent standard errors of the means.
72 h after the final chronic morphine injection
there was no change in the hydroxylation of
tyrosine in whole brain homogenates.
Changes in the activity of an enzyme may occur
in vivo as a result of changes in the local
concentration of inhibitors and where the struc-
tural integrity of the tissue is essential to demon-
strate such changes. Therefore, tyrosine hydroxy-
lase activity was measured in brain slices. The
activity of the enzyme in slices from the dience-
phalon, brainstem and parietal cortex of either
naive or chronically morphine-treated animals was
unaltered by morphine, 3-300 mg/kg. However,
morphine, 100 mg/kg, did significantly increase
(P < 0.05) the activity of tyrosine hydroxylase in
the caudate nucleus (366.9 ± 12.8 to 421.9 ± 21.3;
mean ± s.e.). After nine injections of morphine
this effect disappeared. Thirty-six hours after
abrupt withdrawal from morphine there was a
significant decrease (P < 0.005) in the tyrosine
hydroxylase activity of caudate slices (Figure 1).
In contrast, there were no changes in the activity
of this enzyme in slices from other brain areas over
a 72 h period of withdrawal. When naloxone,
3 mg/kg, was given to mice 6 h after their final
chronic morphine injection, slices from the four
brain areas showed no alteration in tyrosine
hydroxylase activity when studied 70 min after
the injection of the antagonist.
Discussion
The present series of experiments was designed to
determine whether changes in tyrosine hydroxy-
lase activity, measured in vitro, could explain the
changes in catecholamine synthesis produced by
morphine in the mouse brain in vivo. For example,
acute injections of morphine increase the synthesis
of dopamine and noradrenaline in the mouse brain
in vivo (Smith et al., 1970; 1972). The present
experiments suggest that the hydroxylation of
tyrosine in whole brain homogenates does not
change after the acute administration of morphine.
Fukui, Shiomi & Takagi (1972) also found un-
changed tyrosine hydroxylase activity when
morphine, 10-5 to 10-3 M, was added in vitro to
mouse brain homogenates. Smith et al. (1972)
reported increased incorporation in vivo of
[4C] -tyrosine into [14C1 -catecholamines in the
cerebral cortex, diencephalon, striatum, brainstem
and cerebellum of the mouse. However, in the
present study, the activity of tyrosine hydroxylase
was increased only in slices from the caudate
nucleus after the acute administration of mor-
phine.
After the repeated administration of morphine,
tolerance developed to the effects of this drug on
[14C1 -catecholamine synthesis in the mouse brain
(Smith et al., 1972). The present results suggest
that during chronic morphine treatment tolerance
developed to the effect of morphine on the
activity of tyrosine hydroxylase in brain slices
from the caudate nucleus. After chronic morphine
treatment, Reis, Hess & Azmitia (1970) reported
increased tyrosine hydroxylase activity in homo-
genates of rat caudate nucleus in contrast with the
present findings using homogenates of whole
mouse brain.
Rosenman & Smith (1972) reported a decrease
in catecholamine synthesis in the mouse brain on
withdrawal from morphine. This effect on syn-
thesis was at a maximum 36 h after the final
morphine injection. At this time, a significant
decrease in tyrosine hydroxylase activity was seen
in brain slices from the caudate nucleus (Figure 1).
This decrease in activity could explain the decrease
in dopamine synthesis in vivo during withdrawal.
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The activity of the enzyme was unaltered in slices
from the diencephalon, brainstem or parietal
cortex, areas in which noradrenaline is the most
abundant catecholamine. In rats withdrawn from
morphine for 48 h, there was a decreased deple-
tion of dopamine after a-methyl-p-tyrosine
(Gunne, Jonsson & Fuxe, 1969). This suggests
decreased release and possibly a decreased rate of
dopamine turnover and synthesis, in agreement
with the present findings. Naloxone administration
to mice which had chronically received morphine
precipitated a withdrawal syndrome, which
included jumping, diarrhoea and piloerection, but
did not decrease tyrosine hydroxylase activity in
slices from the caudate nucleus. This suggests a
difference between the withdrawal syndrome pro-
duced on termination of drug treatment and that
elicited by a narcotic antagonist.
In conclusion, the assay of tyrosine hydroxy-
lase activity in vitro did not produce results which
could account for the changes in noradrenaline
synthesis produced by morphine in vivo. However,
the changes in tyrosine hydroxylase activity seen
in the caudate nucleus could partly account for
the changes in dopamine synthesis in vivo follow-
ing acute and chronic morphine treatment.
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